SCHEMBL29655267

SCHEMBL29655267

Nc1ccc(-c2ccc(F)cc2)cc1N

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.70
MEN1 O00255 1/20 0.70
KMT2A Q03164 1/20 0.70
KCNH2 Q12809 2/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP17A1 P05093 2/20 0.47
CYP19A1 P11511 2/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
TAAR1 Q96RJ0 1/20 0.45
HDAC2 Q92769 4/20 0.45
MAP4K4 O95819 1/20 0.44
HDAC3 O15379 3/20 0.42
HDAC1 Q13547 3/20 0.42
CYP3A4 P08684 4/20 0.42
TSHR P16473 2/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PGR P06401 1/20 0.41
AGXT P21549 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048618 1.00 TDP1 (0.70) TDP1MEN1KMT2AKCNH2ALDH1A1
SCHEMBL12772920 0.87 TDP1 (0.93) TDP1MEN1KMT2AKCNH2ALDH1A1
Hydrochloric Acid SCHEMBL1646515 0.84 TDP1 (0.88) TDP1MEN1KMT2AKCNH2ALDH1A1
SCHEMBL29349835 0.84 TDP1 (1.00) TDP1MEN1KMT2AKCNH2ALDH1A1
SCHEMBL23855 0.84 TDP1 (1.00) TDP1MEN1KMT2AKCNH2ALDH1A1
SCHEMBL3823490 0.83 ALDH1A1 (0.65) TDP1MEN1KMT2AALDH1A1CYP11B1
SCHEMBL15234491 0.83 CYP1A1 (0.51) TDP1MEN1KMT2AALDH1A1TAAR1
SCHEMBL28701511 0.83 TDP1 (0.67) TDP1MEN1KMT2AKCNH2ALDH1A1
SCHEMBL15234523 0.83 CYP1A1 (0.51) TDP1MEN1KMT2AALDH1A1TAAR1
Water SCHEMBL3137651 0.81 TDP1 (0.93) TDP1MEN1KMT2AKCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed